Literature DB >> 17229228

Patients' willingness to pay for anti-emetic treatment.

H Kerger1, A Turan, M Kredel, U Stuckert, N Alsip, T J Gan, C C Apfel.   

Abstract

BACKGROUND: Post-operative nausea and vomiting (PONV) is a common complication of anaesthesia. This study was conducted in 100 German and 100 Turkish patients scheduled for elective surgery under general anaesthesia to assess the amount patients were willing to pay for an anti-emetic that completely prevented PONV.
METHODS: Post-operatively, using Dixon's up and down method, patients completed an interactive computer questionnaire with a random starting point to determine how much of their own money they were willing to pay for a totally effective anti-emetic treatment.
RESULTS: On average, participants were willing to pay 65 euro in Germany and 68 euro in Turkey to avoid PONV. However, patients who actually experienced PONV were willing to pay larger amounts: 96 euro in Germany and 99 euro in Turkey. The amount patients were willing to pay was related to female sex, history of motion sickness, non-smoking status and better education.
CONCLUSIONS: Despite differences in political and cultural origin, health care system and financial background, the amount patients were willing to pay for an effective anti-emetic was similar in both Germany and Turkey to that reported previously for the USA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229228     DOI: 10.1111/j.1399-6576.2006.01171.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  9 in total

1.  The willingness of patients to pay for intravenous patient-controlled analgesia in Korea.

Authors:  Hyungsun Lim; Duck-Hyoung Lee; Jeongwoo Lee; Young Jin Han; Huhn Choe; Ji-Seon Son
Journal:  Korean J Anesthesiol       Date:  2012-06-19

2.  Determinants of willingness to pay for a new therapy in a sample of menopausal-aged women.

Authors:  Andrej Rasch; Jan-Marc Hodek; Claus Runge; Wolfgang Greiner
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial.

Authors:  Márcio Luiz Benevides; Sérgio S de Souza Oliveira; José E de Aguilar-Nascimento
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

4.  Association between serotonin transport polymorphisms and postdischarge nausea and vomiting in women following breast cancer surgery.

Authors:  Susan W Wesmiller; Catherine M Bender; Susan M Sereika; Gretchen Ahrendt; Marguerite Bonaventura; Dana H Bovbjerg; Yvette Conley
Journal:  Oncol Nurs Forum       Date:  2014-03-01       Impact factor: 2.172

Review 5.  Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting.

Authors:  Charles C Horn; William J Wallisch; Gregg E Homanics; John P Williams
Journal:  Eur J Pharmacol       Date:  2013-10-26       Impact factor: 4.432

6.  [Postoperative complaints : gender differences in expectations, prevalence and appraisal].

Authors:  M Hüppe; A Kemter; C Schmidtke; K-F Klotz
Journal:  Anaesthesist       Date:  2013-06-12       Impact factor: 1.041

7.  Antiemetic efficacy of capsicum plaster on acupuncture points in patients undergoing thyroid operation.

Authors:  Min Seok Koo; Kyo Sang Kim; Hee-Jong Lee; Ji Seon Jeong; Jung-Won Lee
Journal:  Korean J Anesthesiol       Date:  2013-12-26

8.  Assessment of Dog Owner Concern Regarding Peri-operative Nausea and Vomiting and Willingness to Pay for Anti-emetic Treatment.

Authors:  Bonnie L Hay Kraus; Callie Cazlan
Journal:  Front Vet Sci       Date:  2019-08-22

9.  Antiemetic Prophylaxis Practice and its Associated Factors Among Health Professionals in Referral Hospitals of North West Ethiopia: Multicenter Cross-Sectional Study.

Authors:  Yewlsew Fentie; Abraham Tarekegn; Moges Gelaw; Efrem Fenta
Journal:  Int J Surg Protoc       Date:  2021-06-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.